Clinical Trials
2 trialsNCT02911142 2025-07-28
Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma
National Institutes of Health Clinical Center (CC)
Phase 1/2 Active not recruiting
NCT02521129 2015-08-13
A New Track Ablation Device for Liver Biopsy: A Feasibility Study
Samsung Medical Center
Phase 1/2 Unknown